Effect of systemic antibiotics on the outcomes of regenerative periodontal surgery in intrabony defects: a randomized, controlled, clinical study

Objectives To assess the potential influence of systemic antibiotic administration on the healing of periodontal intrabony defects treated with deproteinized bovine bone mineral (DBBM) and collagen membrane. Materials and methods Forty-one intrabony defects were treated by means of DBBM and collagen membrane (GTR). Postoperatively, the patients received either systemic antibiotics (i.e., 1 g of amoxicillin, twice daily for 7 days) (test) or no antibiotics (control). Clinical attachment level (CAL), probing depth (PD), and gingival recession (GR) were measured at baseline and at 1 year following regenerative surgery. The depth of the intrabony component (INTRA DD) and its width (INTRA DW) were measured during surgery and after 1 year at reentry. The depth (RxD) and width (RxW) of the intrabony defects were evaluated radiographically at baseline and at 1 year. Results No adverse events were observed in any of the two groups throughout the entire study period. In the test group, mean CAL changed from 8.7 +/- 1.4 mm at baseline to 5.0 +/- 1.7 mm at 1 year (p < 0.0001), while PD decreased from 7.8 +/- 1.5 mm at baseline to 4.0 +/- 0.9 mm at 1 year (p < 0.0001). In the control group, mean CAL changed from 8.6 +/- 1.9 mm to 5.9 +/- 1.6 mm (p < 0.001) and mean PD improved from 7.4 +/- 1.3 mm to 4.1 +/- 1.3 mm (p < 0.001). Mean CAL gain measured 3.6 +/- 1.6 mm in the test and 2.7 +/- 1.6 mm in the control group, respectively. Defect fill (i.e., INTRA DD gain) at re-entry measured 3.7 +/- 1.8 mm in the test and 2.7 +/- 2.1 mm in the control group. A CAL gain of >= 3 mm was measured in 76% of the defects in the test group and in 40% of the defects in the control group, respectively. In both groups, all evaluated clinical and radiographic parameters improved statistically significantly compared with baseline, but no statistically significant differences were found between the two groups. Conclusions Within their limits, the present study has failed to show any substantial added clinical benefits following the postoperative administration of amoxicillin in conjunction with regenerative periodontal surgery using DBBM and GTR.